WAIKOLOA, Hawaii — At Retina 2019 here, Carl D. Regillo, MD, discusses the latest data on anti-VEGF dosing regimens, which show that, over time, over-treating AMD is likely to yield better visual outcomes than undertreatment.
Uncategorized